Concorde Asset Management’s CVS Health CVS Stock Holding History

Concorde Asset Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,800	Closed	-$367K	–	157
2019 Q2	$367K	Sell	6,800 -2,115	-24%	-$114K	0.21%	133
2019 Q1	$471K	Buy	+8,915	New	+$550K	0.3%	108
2017 Q4	–	Sell	-2,518	Closed	-$205K	–	124
2017 Q3	$205K	Sell	2,518 -116	-4%	-$9.18K	0.18%	140
2017 Q2	$212K	Sell	2,634 -2,242	-46%	-$177K	0.29%	114
2017 Q1	$382K	Buy	+4,876	New	+$389K	0.63%	56
2016 Q3	–	Sell	-2,429	Closed	-$233K	–	123
2016 Q2	$233K	Buy	2,429 +96	+4%	+$9.57K	0.23%	115
2016 Q1	$243K	Buy	2,333 +93	+4%	+$9.04K	0.28%	90
2015 Q4	$221K	Buy	+2,240	New	+$219K	0.25%	99

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Concorde Asset Management's CVS Position: Q3 2019 in Review

Concorde Asset Management sold out of CVS Health (CVS) in Q3 2019, closing a stake of 6,800 shares — an estimated $367K sold.

Concorde Asset Management first reported a position in CVS in Q4 2015 and held it in 8 quarters. The position peaked at $471K in Q1 2019. 1,683 funds tracked by Wall St. Rank hold CVS as of Q3 2019.

Concorde Asset Management reported no remaining CVS Health position as of Q3 2019 after selling out during the quarter.
Concorde Asset Management sold 6,800 CVS Health shares in Q3 2019, an estimated $367K.
Concorde Asset Management first reported a position in CVS Health in Q4 2015 and held it in 8 quarters.
Concorde Asset Management's CVS Health position peaked at $471K in Q1 2019.
1,683 funds tracked by Wall St. Rank held CVS Health as of Q3 2019.

Based on Concorde Asset Management's 13F filing for Q3 2019, filed 28 Oct 2019.